Cargando…

Target product profiles: tests for tuberculosis treatment monitoring and optimization

The World Health Organization has developed target product profiles containing minimum and optimum targets for key characteristics for tests for tuberculosis treatment monitoring and optimization. Tuberculosis treatment optimization refers to initiating or switching to an effective tuberculosis trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta-Wright, Ankur, den Boon, Saskia, MacLean, Emily L, Cirillo, Daniela, Cobelens, Frank, Gillespie, Stephen H, Kohli, Mikashmi, Ruhwald, Morten, Savic, Rada, Brigden, Grania, Gidado, Mustapha, Goletti, Delia, Hanna, Debra, Hasan, Rumina, Hewison, Cathy, Koura, Kobto G, Lienhardt, Christian, Lungu, Patrick, McHugh, Timothy D, McKenna, Lindsay, Scott, Cherise, Scriba, Thomas, Sekaggya-Wiltshire, Christine, Kasaeva, Tereza, Zignol, Matteo, Denkinger, Claudia M, Falzon, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2023
Materias:	Policy & Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630735/ https://www.ncbi.nlm.nih.gov/pubmed/37961060 http://dx.doi.org/10.2471/BLT.23.290901

Ejemplares similares

Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam
por: Brigden, Grania, et al.
Publicado: (2019)

New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
por: Brigden, Grania, et al.
Publicado: (2015)

The impact of the COVID-19 pandemic on the global tuberculosis epidemic
por: Falzon, Dennis, et al.
Publicado: (2023)

Framework for the evaluation of new tests for tuberculosis infection
por: Hamada, Yohhei, et al.
Publicado: (2021)

Call to action for an invigorated drive to scale up TB prevention
por: Kasaeva, T., et al.
Publicado: (2021)

Global reporting on tuberculosis preventive treatment among contacts
por: Falzon, Dennis, et al.
Publicado: (2022)

Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
por: Gupta, Aastha, et al.
Publicado: (2022)

Advances in clinical trial design: Weaving tomorrow’s TB treatments
por: Lienhardt, Christian, et al.
Publicado: (2020)

Priorities for global political momentum to end TB: a critical point in time
por: Kasaeva, Tereza, et al.
Publicado: (2018)

WHO target product profiles for TB preventive treatment
por: Den Boon, S., et al.
Publicado: (2022)

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs
por: Satyanarayana, Srinath, et al.
Publicado: (2023)

The time to act is now: pseudo-systematic review
por: Ford, Nathan, et al.
Publicado: (2020)

Achieving universal access to rapid tuberculosis diagnostics
por: Ismail, Nazir, et al.
Publicado: (2023)

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
por: Petruccioli, Elisa, et al.
Publicado: (2016)

Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda
por: Mitnick, Carole D., et al.
Publicado: (2016)

Biomarkers That Correlate with Active Pulmonary Tuberculosis Treatment Response: a Systematic Review and Meta-analysis
por: Zimmer, Alexandra J., et al.
Publicado: (2022)

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
por: Furin, Jennifer, et al.
Publicado: (2016)

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres
por: MacLean, Emily Lai-Ho, et al.
Publicado: (2023)

Maternal Anaemia at Delivery and Haemoglobin Evolution in Children during Their First 18 Months of Life Using Latent Class Analysis
por: Koura, Kobto G., et al.
Publicado: (2012)

25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward
por: Dean, Anna S, et al.
Publicado: (2022)

Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
por: Esmail, Hanif, et al.
Publicado: (2020)

Pediatric Tuberculosis Research and Development: Progress, Priorities and Funding Opportunities
por: McKenna, Lindsay, et al.
Publicado: (2022)

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
por: Trébucq, Arnaud, et al.
Publicado: (2019)

Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen
por: Mayito, Jonathan, et al.
Publicado: (2020)

World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
por: Mirzayev, Fuad, et al.
Publicado: (2021)

Research on Implementation of Interventions in Tuberculosis Control in Low- and Middle-Income Countries: A Systematic Review
por: Cobelens, Frank, et al.
Publicado: (2012)

‘Out of sight, out of mind?’ A follow-up on HIV-infected patients with drug-resistant pulmonary tuberculosis in Uganda: A case series
por: Notarfrancesco, Marco, et al.
Publicado: (2021)

Multidrug-resistant tuberculosis in children: evidence from global surveillance
por: Zignol, Matteo, et al.
Publicado: (2013)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers
por: Singhroy, Diane N., et al.
Publicado: (2020)

Prevalence and factors associated with psychological distress among patients on warfarin at the Uganda Heart Institute, Mulago Hospital
por: Naisanga, Molly, et al.
Publicado: (2022)

Modernizing Surveillance of Antituberculosis Drug Resistance: From Special Surveys to Routine Testing
por: Zignol, Matteo, et al.
Publicado: (2011)

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2022)

Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally
por: Masini, Tiziana, et al.
Publicado: (2022)

Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape
por: Hamada, Yohhei, et al.
Publicado: (2022)

Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey
por: Tagliani, Elisa, et al.
Publicado: (2017)

Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study
por: Mayito, Jonathan, et al.
Publicado: (2023)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis
por: Baruch Baluku, Joseph, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country
por: Ddungu, Ahmed, et al.
Publicado: (2021)

Advances in Molecular Diagnosis of Tuberculosis
por: MacLean, Emily, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fv8bf1a59c4kto8ekj8rhmidss